SECsense Logo

Silo Pharma, Inc. 8-K Report: Key Insights & Financial Snapshot (Jan 2025)

$SILO
Form 8-K
Filed on: 2025-01-02
Source
Silo Pharma, Inc. 8-K Report: Key Insights & Financial Snapshot (Jan 2025)

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Identification:
  • Company Name: Silo Pharma, Inc.
  • SEC CIK: 0001514183
  • SEC File Number: 001-41512
  • State of Incorporation: Nevada (NV)
  • Tax Identification Number: 27-3046338
  1. Report Type and Date:
  • Filing Type: 8-K (a current report required by the SEC to disclose any material events)
  • Filing Date: January 2, 2025
  1. Contact Information:
  • Address: 677 N. Washington Boulevard, Sarasota, FL 34236
  • Phone Number: 718-400-9031
  1. Stock Information:
  • Common Stock: Par value $0.0001 per share
  • Ticker Symbol: SILO
  • Exchange: NASDAQ
  1. Financial Context:
  • Reporting Period: January 2, 2025 (the same day as the filing date indicates that this may be a snapshot report or event-driven report).
  • Currency: USD (United States Dollar)
  • Measurement Units:
    • USD (monetary value)
    • Shares (for stock-related measurements)

Key Insights:

  • The report pertains to an 8-K filing, which typically indicates that there has been a significant event or announcement regarding the company.
  • The information is structured in XBRL (Extensible Business Reporting Language), which suggests a standardized format for financial reporting to enhance transparency and comparability.
  • The company's presence on NASDAQ and its low par value might be of interest to investors looking for penny stock opportunities or emerging growth companies.

Overall, this report provides a concise overview of Silo Pharma, Inc., including essential details on its corporate structure, stock information, and recent reporting activity.